专利检索 ap:("JANSSEN BIOTECH, INC.") AND inv:"Songmao Zheng" 第 1 页

1.

发明授权
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes 有权

公开(公告)号：US10465003B2

公开(公告)日：2019-11-05

申请号：US15421473

申请日：2017-02-01

申请人： Janssen Biotech, Inc.

发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka

IPC分类号： C07K16/24 , A61P3/10 , A61P29/00 , A61M5/00 , A61M5/315 , A61K39/00

摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

2.

发明申请
ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES 审中-公开

公开(公告)号：US20170247444A1

公开(公告)日：2017-08-31

申请号：US15421473

申请日：2017-02-01

申请人： Janssen Biotech, Inc.

发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka

IPC分类号： C07K16/24

CPC分类号： C07K16/241 , A61K2039/505 , A61K2039/545 , A61M5/003 , A61M5/31533 , A61M5/31573 , A61M5/31591 , A61P3/10 , A61P29/00 , C07K2317/21 , C07K2317/565

摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

3.

发明公开
USES OF CD79B ANTIBODIES FOR AUTOIMMUNE THERAPEUTIC APPLICATIONS 审中-公开

公开(公告)号：US20240158499A1

公开(公告)日：2024-05-16

申请号：US18549665

申请日：2022-03-11

申请人： JANSSEN BIOTECH, INC.

发明人： Songmao Zheng , John Emery , Jennifer F. Nemeth , Fang Shen , Pankaj Seth

IPC分类号： C07K16/28 , A61K39/00

CPC分类号： C07K16/2803 , A61K2039/505 , C07K2317/565 , C07K2317/622

摘要： The invention provides antigen binding domains that bind Cluster of Differentiation 79B protein (CD79B) protein comprising the antigen binding domains that bind CD79b, polynucleotides encoding them, vectors, host cells, methods of making and using them.

4.

发明授权
Method for treating pre-type 1 diabetes in a human subject 有权

公开(公告)号：US11124565B2

公开(公告)日：2021-09-21

申请号：US16540388

申请日：2019-08-14

申请人： Janssen Biotech, Inc.

发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka

IPC分类号： C07K16/24 , A61P3/10 , A61P29/00 , A61M5/00 , A61M5/315 , A61K39/00

摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

5.

发明申请
ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES 审中-公开

公开(公告)号：US20190092849A1

公开(公告)日：2019-03-28

申请号：US16070385

申请日：2017-02-02

申请人： Janssen Biotech, Inc.

发明人： Joseph Hedrick , Elizabeth C. Hsia , Paul Imm , Jocelyn Leu , Bethany Paxson , Mark Rigby , Songmao Zheng , Ramineh Zoka

IPC分类号： C07K16/24 , A61P29/00 , A61P3/10 , A61M5/00 , A61M5/315

摘要： The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).